Bendamustine, etoposide, and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in non-Hodgkin lymphoma

BACKGROUND: Bendamustine is a chemotherapeutic agent that has shown broad activity in patients with lymphoid malignancies. It contains both alkylating and nucleoside analog moieties, and thus, is not commonly used for stem cell mobilization due to concerns that it may adversely affect stem cell coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenbaum, Adam M., Green, Damian J., Holmberg, Leona A., Gooley, Ted, Till, Brian G., Budde, Lihua E., Rasmussen, Heather, Press, Oliver W., Gopal, Ajay K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170297/
https://www.ncbi.nlm.nih.gov/pubmed/30310789
http://dx.doi.org/10.5045/br.2018.53.3.223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170297/
https://www.ncbi.nlm.nih.gov/pubmed/30310789
http://dx.doi.org/10.5045/br.2018.53.3.223

Ejemplares similares